Page last updated: 2024-10-24

verapamil and Coronary Restenosis

verapamil has been researched along with Coronary Restenosis in 4 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kullmann, S1
Binner, P1
Rackebrandt, K1
Huge, A1
Haltern, G1
Lankisch, M1
Füth, R1
von Hodenberg, E2
Bestehorn, HP2
Scheffold, T1
Neumann, FJ1
Büttner, HJ1
Betz, P1
Stürzenhofecker, P1
Verdun, A1
Levai, L1
Monassier, JP1
Roskamm, H1
Matsuo, H1
Watanabe, S1
Watanabe, T1
Warita, S1
Kojima, T1
Hirose, T1
Iwama, M1
Ono, K1
Takahashi, H1
Segawa, T1
Minatoguchi, S1
Fujiwara, H1
Wei, W1
Floten, HS1
He, GW1

Trials

4 trials available for verapamil and Coronary Restenosis

ArticleYear
Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.
    BMC cardiovascular disorders, 2009, Oct-08, Volume: 9

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Case-Control Studies; Coronar

2009
Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Even
    Journal of the American College of Cardiology, 2004, Jun-16, Volume: 43, Issue:12

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Calcium Channe

2004
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
    American heart journal, 2007, Volume: 154, Issue:5

    Topics: Aged; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Cor

2007
Interaction between vasodilators and vasopressin in internal mammary artery and clinical significance.
    The Annals of thoracic surgery, 2002, Volume: 73, Issue:2

    Topics: Arginine Vasopressin; Coronary Artery Bypass; Coronary Restenosis; Culture Techniques; Diltiazem; Do

2002